Levetiracetam Solution
Product Images NDC 51672-4136

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 51672-4136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levetiracetam 01)

Chemical structure diagram of levetiracetam, showing its molecular arrangement including a pyrrolidone ring and functional groups as part of its active ingredient representation.*

FDA Label Image

Figure 1 (Levetiracetam 02)

A vertical bar chart showing the percentage of patients corresponding to three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The x-axis lists the groups with patient counts, and the y-axis represents the percentage of patients from 0% to 45%.*

FDA Label Image

Figure 2 (Levetiracetam 03)

A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The y-axis represents the percentage of patients, showing increases from placebo to higher Levetiracetam doses, with specific percentages labeled above each bar.*

FDA Label Image

Figure 3 (Levetiracetam 04)

A bar graph comparing the percentage of patients between placebo and Levetiracetam 3000 mg/day treatment groups. The placebo group (N=104) shows 14.4% while the Levetiracetam group (N=180) shows 39.4%. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Figure 4 (Levetiracetam 05)

A bar chart comparing the percentage of patients between placebo and Levetiracetam groups, showing approximately 19.6% for placebo and 44.6% for Levetiracetam (100 mg/mL). The x-axis labels groups as Placebo (N=97) and Levetiracetam (N=101). The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Figure 5 (Levetiracetam 06)

A bar chart comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The Placebo group shows approximately 19.6% of patients, while the Levetiracetam group shows about 43.1% of patients. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Figure 6 (Levetiracetam 07)

Bar graph comparing percentage of patients between placebo and Levetiracetam groups. The graph shows approximately 45.2% of patients in the placebo group and 72.2% in the Levetiracetam group, with the latter marked by an asterisk. X-axis labels indicate the number of patients in each group, and the Y-axis shows percentage from 0% to 100%.*

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Levetiracetam Tablets, USP 250 mg carton label showing 30 tablets. The label includes storage instructions, pharmacist dispensing guidance, manufacturer details (Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel), and distributor information (Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY). A barcode and NDC 51672-4141-6 are visible. The label notes 'Rx only' and instructs dispensing with a child-resistant closure.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Label for Levetiracetam Tablets, USP 500 mg, featuring a 30-tablet count. The label includes storage instructions, pharmacist dispensing guidance, and notes on packaging. Manufactured by Taro Pharmaceutical Industries Ltd and distributed by Taro Pharmaceuticals U.S.A., Inc. The label emphasizes "Rx only" status and includes a National Drug Code (NDC) barcode.*

FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Levetiracetam Tablets, USP 750 mg bottle label from Taro Pharmaceuticals. The label shows a barcode, quantity of 30 tablets, dispensing instructions, storage conditions, and trademark information. It includes a pharmacist warning about the Medication Guide requirement. The label indicates prescription use only (Rx only).*

FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Label)

Levetiracetam Tablets, USP 1000 mg bottle label by Taro Pharmaceuticals. The label indicates 30 tablets per bottle and includes storage instructions and dispensing guidelines. It is marked Rx only and lists Taro Pharmaceutical Industries Ltd. as the manufacturer and Taro Pharmaceuticals U.S.A., Inc. as the distributor.*

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Label for Levetiracetam Oral Solution, USP 100 mg/mL in a 16 fl oz (473 mL) container. The label includes storage instructions, pharmacist warning to dispense with medication guide and child-resistant closure. Manufactured by Taro Pharmaceutical Industries Ltd., distributed by Taro Pharmaceuticals U.S.A., Inc. The label features the TARO logo and an NDC barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.